Standard
Medtronic Secures Regulatory Clearances for Advanced Pulsed Field Ablation Software to Strengthen Position in Competitive Cardiac Mapping Market
Medtronic, a global leader in medical technology, has achieved significant regulatory milestones with the receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance and a CE mark for its latest cardiac mapping and navigation software. The approvals for the Affera Prism-2 software and expanded capabilities for the PulseSelect Pulsed Field Ablation (PFA) system mark…
